Chemours/$CC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Chemours
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
- Ticker
- $CC
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 5,700
- Headquarters
- Wilmington, United States
- Website
- www.chemours.com
Chemours Metrics
BasicAdvanced
$2B
-
-$1.02
1.47
$0.35
2.62%
Price and volume
Market cap
$2B
Beta
1.47
52-week high
$28.67
52-week low
$10.44
Average daily volume
2.4M
Dividend rate
$0.35
Financial strength
Current ratio
1.811
Quick ratio
0.907
Long term debt to equity
25.481
Total debt to equity
26.224
Interest coverage (TTM)
0.61%
Profitability
EBITDA (TTM)
533
Gross margin (TTM)
15.27%
Net profit margin (TTM)
-2.64%
Operating margin (TTM)
3.65%
Effective tax rate (TTM)
216.54%
Revenue per employee (TTM)
$1,020,000
Management effectiveness
Return on assets (TTM)
1.79%
Return on equity (TTM)
-67.98%
Valuation
Price to revenue (TTM)
0.345
Price to book
12.96
Price to tangible book (TTM)
18.78
Price to free cash flow (TTM)
9.551
Free cash flow yield (TTM)
10.47%
Free cash flow per share (TTM)
1.398
Dividend yield (TTM)
2.62%
Forward dividend yield
2.62%
Growth
Revenue change (TTM)
0.09%
Earnings per share change (TTM)
-56.41%
3-year revenue growth (CAGR)
-0.91%
10-year revenue growth (CAGR)
0.72%
3-year earnings per share growth (CAGR)
-21.69%
10-year earnings per share growth (CAGR)
2.14%
3-year dividend per share growth (CAGR)
-55.60%
10-year dividend per share growth (CAGR)
-3.11%
What the Analysts think about Chemours
Analyst ratings (Buy, Hold, Sell) for Chemours stock.
Analyst projections of the future price of Chemours stock.
Bulls say / Bears say
Titanium Technologies is showing pricing power: third-quarter TiO₂ pricing rose 10% year on year and segment adjusted EBITDA increased to $85 million from $25 million. This supports the case that Chemours can improve earnings even while demand remains uneven. (Chemours)
The completed Kuan Yin property sale brought total net consideration of about $340 million, while management expects 2026 net leverage below 4.2x. The proceeds and planned debt reduction offer a route to greater financial flexibility. (Chemours)
Thermal & Specialized Solutions remains exposed to weak refrigerant aftermarket demand and excess channel inventory. Third-quarter sales fell 9% year on year and adjusted EBITDA fell 30%, with further seasonal sales declines expected in the fourth quarter. (Chemours)
Legacy litigation remains a significant financial risk: accrued litigation reached $658 million at the end of June, up from $484 million at the end of 2025. Chemours warns that adverse outcomes could lead to losses above accrued liabilities. (SEC)
Leverage remains high, with $3.2 billion of net debt and a 4.3x net leverage ratio at the end of the third quarter. The full-year cash-conversion outlook is above 15% and includes restricted PFAS insurance proceeds, while legal settlement payments also weigh on cash available for debt reduction. (Chemours)
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2026.
Chemours Financial Performance
Revenues and expenses
Chemours Earnings Performance
Company profitability
Upcoming events
Chemours News
AllArticlesVideos
Kaplan Fox Notifies Investors of The Chemours Company (CC) of the Lead Plaintiff Deadline on December 7, 2026
Newsfile Corp15 hours ago
Did You Lose Money on The Chemours Company Stock? Faruqi & Faruqi, LLP Reminds Investors of December 7, 2026 Lead Plaintiff Deadline in Securities Class Action After 18.63% Share Price Decline
Newsfile Corp17 hours ago
CC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds The Chemours (CC) Investors of Securities Class Action Lawsuit Deadline on December 7, 2026
Newsfile Corp2 days ago
Funds containing Chemours
Fund name | Fund size | $CC weighting |
|---|---|---|
L&G Hydrogen Economy$HTWO | $464M | 2.49% |
iShares S&P SmallCap 600$IDP6 | $2.5B | 0.11% |
iShares S&P Small Cap 600£ISP6 | $2.5B | 0.11% |
SPDR Russell 2000 US Small Cap€R2US | $4.7B | 0.07% |
SPDR Russell 2000 US Small Cap£R2SC | $4.7B | 0.07% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.